Becton, Dickinson and Company (BDX) Stock Forecast & Price Target

$144.99 +0.82 (+0.57%)

Closing price 03:59 PM Eastern

Extended Trading

$146.37 +1.38 (+0.95%)

As of 07:44 PM Eastern

Compare

Becton, Dickinson and Company - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Hold

Based on 16 Analyst Ratings

Sell
0

Hold
9

Buy
7

Based on 16 Wall Street analysts who have issued ratings for Becton, Dickinson and Company in the last 12 months, the stock has a consensus rating of "Hold." Out of the 16 analysts, 9 have given a hold rating, and 7 have given a buy rating for BDX.

Consensus Price Target

$186.57
28.68% Upside

According to the 16 analysts' twelve-month price targets for Becton, Dickinson and Company, the average price target is $186.57. The highest price target for BDX is $232.00, while the lowest price target for BDX is $157.00. The average price target represents a forecasted upside of 28.68% from the current price of $144.99.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for BDX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Becton, Dickinson and Company and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BDX Analyst Ratings Over Time

Type	Current Forecast 5/6/25 to 5/6/26	1 Month Ago 4/6/25 to 4/6/26	3 Months Ago 2/5/25 to 2/5/26	1 Year Ago 5/6/24 to 5/6/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	7 Buy rating(s)	6 Buy rating(s)	5 Buy rating(s)	5 Buy rating(s)
Hold	9 Hold rating(s)	10 Hold rating(s)	8 Hold rating(s)	6 Hold rating(s)
Sell	0 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$186.57	$191.62	$213.36	$231.44
Forecasted Upside	28.68% Upside	23.52% Upside	3.37% Upside	40.16% Upside
Consensus Rating	Hold	Hold	Hold	Hold

BDX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

BDX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Becton, Dickinson and Company Stock vs. The Competition

Type	Becton, Dickinson and Company	Medical Companies	S&P 500
Consensus Rating Score	2.44	2.30	2.52
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	28.68% Upside	912.84% Upside	13.98% Upside
News Sentiment Rating	Positive News See Recent BDX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/4/2026	TD Cowen 3 of 5 stars	Joshua Jennings Not Rated	Lower Target	Hold	$189.00 ➝ $163.00	+8.66%
5/4/2026	Evercore 3 of 5 stars		Initiated Coverage	Outperform	$180.00	+20.02%
4/17/2026	Piper Sandler 2 of 5 stars	Jason Bednar 2 of 5 stars	Lower Target	Neutral	$170.00 ➝ $159.00	+2.65%
4/14/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$175.00	+12.64%
4/10/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Roman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy ➝ Neutral	$167.00	+8.41%
4/10/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong Sell ➝ Hold
3/23/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Toung Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$230.00 ➝ $180.00	+15.17%
2/10/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Taylor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$220.00 ➝ $190.00	+10.70%
2/10/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joanna Wiensch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$233.00 ➝ $232.00	+36.22%
2/10/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Marcus Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$190.00 ➝ $175.00	+4.89%

2/10/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lawrence Biegelsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$184.00 ➝ $157.00	-24.27%
2/10/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Miksic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Overweight	$202.00	-2.56%
1/7/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rick Wise Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$210.00 ➝ $215.00	+4.75%
1/5/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Travis Steed Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$190.00 ➝ $207.00	+6.30%
12/2/2025	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$197.00 ➝ $210.00	+9.45%
10/8/2025	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Hold (C-)
5/2/2025	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jayson Bedford Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
5/1/2025	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Weinstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 11:47 PM ET.

Should I Buy Becton, Dickinson and Company Stock? BDX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, May 6, 2026. Please send any questions or comments about these Becton, Dickinson and Company pros and cons to contact@marketbeat.com.

Becton, Dickinson and Company
Bull Case

Here are some ways that investors could benefit from investing in Becton, Dickinson and Company:

The current stock price is around $149, which may present a buying opportunity for investors looking for value in the medical technology sector.
Becton, Dickinson and Company has a strong history of dividend payments, with a recent quarterly dividend of $1.05 per share, translating to an annualized dividend yield of 2.8%. This can provide a steady income stream for investors.
The company reported earnings per share of $2.91, exceeding analysts' expectations, indicating strong financial performance and potential for future growth.
With a market capitalization of approximately $42.53 billion, Becton, Dickinson and Company is a significant player in the medical technology field, which can offer stability and growth potential.
The firm has initiated a share buyback program, which often signals that management believes the stock is undervalued, potentially leading to an increase in stock price as shares are repurchased.

Becton, Dickinson and Company
Bear Case

Investors should be bearish about investing in Becton, Dickinson and Company for these reasons:

The company’s revenue for the latest quarter was $4.49 billion, which fell short of analysts' expectations, suggesting potential challenges in meeting future growth targets.
With a debt-to-equity ratio of 0.67, while manageable, it indicates that the company has a moderate level of debt, which could pose risks in a rising interest rate environment.
The stock has experienced volatility, with a one-year high of $187.35 and a low of $127.59, which may concern risk-averse investors.
The current ratio of 1.05 suggests that the company has just enough short-term assets to cover its short-term liabilities, indicating potential liquidity concerns.
Analysts have mixed ratings on the stock, with some recent price target reductions, which may reflect uncertainty about the company's future performance.

BDX Forecast - Frequently Asked Questions

: According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Becton, Dickinson and Company is $186.57, with a high forecast of $232.00 and a low forecast of $157.00.
: 16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Becton, Dickinson and Company in the last twelve months. There are currently 9 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" BDX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BDX, but not buy additional shares or sell existing shares.
: According to analysts, Becton, Dickinson and Company's stock has a predicted upside of 28.68% based on their 12-month stock forecasts.
: Over the previous 90 days, Becton, Dickinson and Company's stock had 2 upgrades and 1 downgrade by analysts.
: Becton, Dickinson and Company has been rated by research analysts at Argus, Barclays, Citigroup, Evercore, Jefferies Financial Group, JPMorgan Chase & Co., Piper Sandler, Royal Bank Of Canada, TD Cowen, The Goldman Sachs Group, Wells Fargo & Company, and Zacks Research in the past 90 days.
: Analysts like Becton, Dickinson and Company more than other "medical" companies. The consensus rating score for Becton, Dickinson and Company is 2.44 while the average consensus rating score for "medical" companies is 2.30. Learn more on how BDX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Becton, Dickinson and Company Recommendations

This page (NYSE:BDX) was last updated on 5/6/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Becton, Dickinson and Company (BDX) Stock Forecast & Price Target

Becton, Dickinson and Company - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

BDX Analyst Ratings Over Time

BDX Analyst Recommendations By Month

BDX Price Targets by Month

Becton, Dickinson and Company Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Becton, Dickinson and Company Stock? BDX Pros and Cons Explained

Becton, Dickinson and Company
Bull Case

Becton, Dickinson and Company
Bear Case

BDX Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Becton, Dickinson and Company Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Becton, Dickinson and Company (BDX) Stock Forecast & Price Target

Becton, Dickinson and Company - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

BDX Analyst Ratings Over Time

BDX Analyst Recommendations By Month

BDX Price Targets by Month

Becton, Dickinson and Company Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Becton, Dickinson and Company Stock? BDX Pros and Cons Explained

Becton, Dickinson and Company Bull Case

Becton, Dickinson and Company Bear Case

BDX Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Becton, Dickinson and Company Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Becton, Dickinson and Company
Bull Case

Becton, Dickinson and Company
Bear Case